Aug 10, 2026 06:52AM
Aug 5, 2026 04:07PM
Jun 4, 2026 08:02AM
Apr 30, 2026 04:30PM
Apr 30, 2026 07:55AM
Apr 30, 2026 07:55AM
Apr 29, 2026 07:25AM H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS)
Apr 28, 2026 08:01AM
Apr 28, 2026 08:01AM
Apr 7, 2026 12:42PM
Apr 7, 2026 08:05AM
Mar 25, 2026 04:15PM
Mar 25, 2026 04:15PM
Feb 26, 2026 04:05PM Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 12, 2026 06:00PM
Feb 12, 2026 06:00PM
Dec 12, 2025 08:30AM
Dec 12, 2025 08:30AM
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM
Oct 29, 2025 04:15PM Emergent BioSolutions Reports Third Quarter 2025 Financial Results
Sep 24, 2025 04:05PM
Sep 16, 2025 06:57AM
Sep 15, 2025 08:36AM
Sep 15, 2025 08:35AM
Sep 11, 2025 06:49AM
Sep 9, 2025 07:31AM
Sep 9, 2025 07:30AM Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Prepar
Sep 3, 2025 06:49AM
Aug 29, 2025 08:05AM
Aug 21, 2025 08:45AM
Aug 6, 2025 04:15PM
Jul 28, 2025 08:50AM
Jul 2, 2025 04:05PM
Jul 2, 2025 04:05PM Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
Jun 18, 2025 08:45AM
Jun 5, 2025 07:00AM
Jun 5, 2025 07:00AM
May 7, 2025 04:05PM
May 1, 2025 05:07PM
Mar 20, 2025 08:06AM
Mar 13, 2025 08:29AM Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
Mar 10, 2025 09:15AM
Mar 10, 2025 09:14AM
Mar 3, 2025 04:23PM
Feb 7, 2025 08:06AM
Jan 21, 2025 06:45AM
Jan 16, 2025 08:00AM
Jan 14, 2025 07:31AM Emergent BioSolutions (EBS) Gains Exclusive Commercial Rights to KLOXXADO Nasal Spray from Hikma Pharmaceuticals
Jan 14, 2025 07:30AM

328,433 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All